Ministry to shorten study period on drug for asbestos-linked cancer
19th Nov 2005, 18:33 GMT
The Ministry of Health, Labor and Welfare has decided to shorten the review period on a drug effective for mesothelioma, a type of lung cancer caused by asbestos exposure. Under its priority review system for drug evaluation, the ministry will sho...
Ministry to shorten study period on drug for asbestos-linked cancer related news:
- AstraZeneca starts key study for new cancer drug — Reuters: Shares
- Workplace asbestos exposure linked to colon cancer — UK labour news from LabourStart
- Drug may stem weight loss during radiation treatments — Medical News Today RSS/XML Feed
- Bristol-Myers Squibb drug may prevent weight loss in cancer — Pharmaceutical Business Review Online
- Gloomy asbestos study criticized at senate hearing. — Environmental Health News
- Male infertility linked to cancer — United Press International - NewsTrack
- Oral WHAT?! — .: UNEASYsilence :.
- Low-calorie sweetener linked to increased cancer risk — Health News
- Drug may combat weight loss during radiation treatments — EurekAlert! - Breaking News
- Erbitux produces survival benefit in head and neck cancer — Pharmaceutical Business Review Online